Rare disease research news from UMass Chan Medical School
-
Jan 10, 2023Read more
-
Dec 27, 2022
Top story: UMass Chan launches Translational Institute for Molecular Therapeutics
Read more -
Nov 8, 2022
NTSAD to honor Guangping Gao for lifetime work on Canavan disease, as gene therapy trial shows promise
Read more -
Oct 19, 2022
Study of rare bone disease led by UMass Chan researcher Jae-Hyuck Shim reaches important milestone
Read more -
Aug 1, 2022
Turning muscle into a protein factory for gene therapy treatments
Read more -
Jun 7, 2022
Eric Baehrecke, Jeanne Lawrence and Alan Mullen appointed to endowed chairs
Read more -
Apr 21, 2022
UMass Chan research supports development of new suppressor-tRNA-based gene therapies
Read more -
Mar 17, 2022
Muscle stem cell technology developed at UMass Chan prelude to new muscular dystrophy therapeutics
Read more -
Feb 14, 2022
First gene therapy for Tay-Sachs disease successfully given to two children
Read more -
Feb 10, 2022
Raiden Science Foundation makes gift to UMass Chan for UBA5 gene therapy research
Read more -
Feb 10, 2022
UMass Chan launches Translational Institute for Molecular Therapeutics
Read more -
Dec 23, 2021
UMass Chan clinical trial shows antisense oligonucleotide safely suppresses mutant ALS gene in pilot human study
Read more -
Nov 18, 2021
Flotte lab to develop gene therapy models for genetic lung disease
Read more -
Nov 2, 2021
Sio Gene Therapies reports positive interim data for gene therapy trial
Read more -
Oct 4, 2021
Riaan Research Initiative funds Cockayne syndrome gene replacement therapy research at UMass Chan Medical School
Read more -
Aug 26, 2021
Behind the research: Jae-Hyuck Shim strives to unlock cure for devastating childhood bone disease
Read more -
Aug 17, 2021
Two new studies from Daryl Bosco lab shed new light on ALS mechanisms
Read more -
Jul 29, 2021
Guangping Gao and Dan Wang partner with ASC Therapeutics to develop novel gene therapy for maple syrup urine disease
Read more -
Apr 27, 2021
USA Today reports on first baby in gene therapy clinical trial for Sandhoff, Tay-Sachs diseases
Read more -
Apr 21, 2021
FDA clears investigational new drug application for ALS gene therapy candidate
Read more